Schetelig, J <br/><br/>
Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.  [electronic resource] 

 -  Bone marrow transplantation  Mar 2004 
 - 483-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1704384  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adult<br/>Aged<br/>Antilymphocyte Serum--administration & dosage<br/>Busulfan--administration & dosage<br/>Chronic Disease<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Graft vs Host Disease--mortality<br/>Hematologic Neoplasms--drug therapy<br/>Hematopoiesis<br/>Hematopoietic Stem Cell Transplantation<br/>Histocompatibility Testing<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Incidence<br/>Male<br/>Middle Aged<br/>Recurrence<br/>Retrospective Studies<br/>Siblings<br/>Survival Analysis<br/>Transplantation Conditioning--methods<br/>Transplantation, Homologous<br/>Treatment Failure<br/>Vidarabine--administration & dosage